Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.
Morovat A, Weerasinghe G, Nesbitt V, Hofer M, Agnew T, Quaghebeur G, Sergeant K, Fratter C, Guha N, Mirzazadeh M, Poulton J. Morovat A, et al. Among authors: guha n. J Clin Med. 2017 Aug 21;6(8):80. doi: 10.3390/jcm6080080. J Clin Med. 2017. PMID: 28825656 Free PMC article.
Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease.
Schober FA, Tang JX, Sergeant K, Moedas MF, Zierz CM, Moore D, Smith C, Lewis D, Guha N, Hopton S, Falkous G, Lam A, Pyle A, Poulton J, Gorman GS, Taylor RW, Freyer C, Wredenberg A. Schober FA, et al. Among authors: guha n. Hum Mol Genet. 2022 Jun 22;31(12):2049-2062. doi: 10.1093/hmg/ddac002. Hum Mol Genet. 2022. PMID: 35024855 Free PMC article.
Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
Guha N, Erotokritou-Mulligan I, Burford C, Strobridge G, Brigg J, Drake T, Bassett EE, Cowan D, Bartlett C, Sönksen PH, Holt RI. Guha N, et al. J Clin Endocrinol Metab. 2010 Jun;95(6):2969-76. doi: 10.1210/jc.2010-0008. Epub 2010 Apr 21. J Clin Endocrinol Metab. 2010. PMID: 20410221
IGF-I abuse in sport.
Guha N, Dashwood A, Thomas NJ, Skingle AJ, Sönksen PH, Holt RI. Guha N, et al. Curr Drug Abuse Rev. 2009 Sep;2(3):263-72. doi: 10.2174/1874473710902030263. Curr Drug Abuse Rev. 2009. PMID: 20443773 Review.
The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Erotokritou-Mulligan I, Guha N, Stow M, Bassett EE, Bartlett C, Cowan DA, Sönksen PH, Holt RI. Erotokritou-Mulligan I, et al. Among authors: guha n. Growth Horm IGF Res. 2012 Apr;22(2):53-8. doi: 10.1016/j.ghir.2011.12.005. Epub 2012 Feb 10. Growth Horm IGF Res. 2012. PMID: 22305721
The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
Guha N, Erotokritou-Mulligan I, Bartlett C, Cowan DA, Bassett EE, Stow M, Sönksen PH, Holt RI. Guha N, et al. Drug Test Anal. 2012 Jun;4(6):455-9. doi: 10.1002/dta.1339. Epub 2012 Apr 17. Drug Test Anal. 2012. PMID: 22511534
144 results